Everolimus - NDC Database

53 records found
Page:1Next PageLast Page
0054-0470 Mar 10, 2020
Everolimus .25 mg Oral Tablet by Hikma Pharmaceuticals USA Inc.
0054-0471 Mar 10, 2020
Everolimus .5 mg Oral Tablet by Hikma Pharmaceuticals USA Inc.
0054-0472 Mar 10, 2020
Everolimus .75 mg Oral Tablet by Hikma Pharmaceuticals USA Inc.
0054-0480 Jun 08, 2020
Everolimus 2.5 mg Oral Tablet by Hikma Pharmaceuticals USA Inc.
0054-0481 Jun 08, 2020
Everolimus 5 mg Oral Tablet by Hikma Pharmaceuticals USA Inc.
0054-0482 Jun 08, 2020
Everolimus 10 mg Oral Tablet by Hikma Pharmaceuticals USA Inc.
0054-0497 Jun 08, 2020
Everolimus 7.5 mg Oral Tablet by Hikma Pharmaceuticals USA Inc.
0054-0604 Nov 18, 2021
Everolimus 1 mg Oral Tablet by Hikma Pharmaceuticals USA Inc.
0093-7766 Jun 10, 2020
Everolimus 2.5 mg Oral Tablet by Teva Pharmaceuticals USA, Inc.
0093-7767 Jun 10, 2020
Everolimus 5 mg Oral Tablet by Teva Pharmaceuticals USA, Inc.
0093-7768 Jun 10, 2020
Everolimus 7.5 mg Oral Tablet by Teva Pharmaceuticals USA, Inc.
0093-7769 Oct 23, 2023
Everolimus 10 mg Oral Tablet by Teva Pharmaceuticals USA, Inc.
0245-0822 Oct 01, 2021
Torpenz 2.5 mg Oral Tablet by Upsher-smith Laboratories, LLC
0245-0823 Oct 01, 2021
Torpenz 5 mg Oral Tablet by Upsher-smith Laboratories, LLC
0245-0824 Oct 01, 2021
Torpenz 7.5 mg Oral Tablet by Upsher-smith Laboratories, LLC
0245-0825 Oct 01, 2021
Torpenz 10 mg Oral Tablet by Upsher-smith Laboratories, LLC
0378-0005 Oct 01, 2021
Everolimus 2 mg Oral Tablet, for Suspension by Mylan Pharmaceuticals Inc.
0378-0006 Oct 01, 2021
Everolimus 3 mg Oral Tablet, for Suspension by Mylan Pharmaceuticals Inc.
0378-0007 Oct 01, 2021
Everolimus 5 mg Oral Tablet, for Suspension by Mylan Pharmaceuticals Inc.
0378-3096 Dec 15, 2022
Everolimus 2.5 mg Oral Tablet by Mylan Pharmaceuticals Inc.
Page:1Next PageLast Page
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.